Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Intel: Meet The New Voice In Health Care: Alexa Is Empowering Patients, Doctors

Executive Summary

Already used by tens of millions of consumers, voice assistants such as Amazon's Alexa are increasingly making their way into hospitals and health organizations. This article outlines multiple use cases where voice is deployed in health systems today, while offering expert insights on trends, opportunities and challenges in this growing space.

You may also be interested in...



LifePod Debuts 'Proactive' Voice Assistant Designed To Ease Elder Care

In October, health IT startup LifePod will debut its proactive voice-assistant device for caregivers to help improve care of the elderly. The device differs from other voice services by including a proactive dialogue to remind the aging person of appointments, events and medications, and gives caregivers real-time feedback on how well patients are doing.

Connected Health Summit: VCs Discuss Digital Health Investment

An expert panel at the Connected Health Summit in San Diego discussed opportunities and challenges in digital health investment and offered "do's and don'ts" for talking to potential investors.

Market Brief: New Triple-Combination Therapies Help Boost Lackluster Inhalation Devices Market

The inhalation devices market will reach $12bn by 2023, driven by the rising prevalence of asthma and COPD worldwide. GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim dominate worldwide sales of inhalation products for asthma and COPD, and are facing generic competition. Generics developers and major pharma players are trying to set themselves apart with better drug-delivery devices. 

Topics

Related Companies

UsernamePublicRestriction

Register

MT125834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel